Try our mobile app

General information

Country: UNITED STATES

Sector: Medical Devices

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Website: abbott.com


  • Pretty weak financial results growth rate 6.3% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-2.2%)
  • Dividend yield for the last twelve months 2.0%
  • Free cash flow yield 0.6% (LTM)
  • Share price is 26.7% higher than minimum and 19.2% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (26.6x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $18.4 mln (-0.009% of cap.)

Key Financials (Download financials)

Ticker: ABT
Share price, USD:  (+1.6%)114.23
year average price 111.45  


year start price 109.03 2023-12-23

max close price 120.96 2024-03-08

min close price 100.07 2024-07-18

current price 114.23 2024-12-21
Common stocks: 1 746 881 140

Dividend Yield:  2.0%
FCF Yield LTM: 0.6%
EV / LTM EBITDA: 26.6x
EV / EBITDA annualized: 25.9x
Last revenue growth (y/y):  +4.0%
Last growth of EBITDA (y/y):  +8.6%
Historical revenue growth:  +1.1%
Historical growth of EBITDA:  -5.4%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 199 546
Net Debt ($m): 7 786
EV (Enterprise Value): 207 332
EBITDA LTM ($m): 7 809
EV / LTM EBITDA: 26.6x
Price to Book: 5.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-12-21seekingalpha.com

Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline

2024-12-21fool.com

My Top 10 Stocks to Buy for 2025

2024-12-19zacks.com

4 Healthcare Technology Innovators to Invest in Before the New Year

2024-12-19zacks.com

Reasons to Retain ABT Stock in Your Portfolio Now

2024-12-18zacks.com

ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker

2024-12-18fool.com

The Smartest Dividend Stocks to Buy With $500 Right Now

2024-12-17zacks.com

Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know

2024-12-17prnewswire.com

Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart

2024-12-13prnewswire.com

Abbott Increases Quarterly Dividend for 53rd Consecutive Year

2024-12-11zacks.com

Abbott (ABT) Stock Sinks As Market Gains: Here's Why
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data